Biomedical Prevention: State of the Science

Preexposure prophylaxis (PrEP) and treatment as prevention (TasP) involve the use of antiretroviral (ARV) drugs by human immunodeficiency virus (HIV)-negative and -positive individuals to reduce HIV acquisition and transmission, respectively. Clinical science has delivered a consistently high effect...

Descripción completa

Detalles Bibliográficos
Autores principales: McCormack, Sheena M., Gafos, Mitzy, Desai, Monica, Cohen, Myron S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Controlling the HIV Epidemic with Antiretrovirals
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060254/
https://www.ncbi.nlm.nih.gov/pubmed/24926033
http://dx.doi.org/10.1093/cid/ciu297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060254/
https://www.ncbi.nlm.nih.gov/pubmed/24926033
http://dx.doi.org/10.1093/cid/ciu297

Ejemplares similares